Work

Universal CMV Prophylaxis Mitigates the Risks of Basiliximab Induction in Heart Transplant Recipients at Intermediate Risk (R+) for Post-Transplant CMV Complications

Year: 2021

Type: article

Study design: Observational Study

Source: The Journal of Heart and Lung Transplantation

DOI: 10.1016/j.healun.2021.01.372

Authors: T. Alexy, A. Morris, M. Flattery, J. Ortega-Legaspi, A. Devore, P. Shah, S. Sinha, R.T. Cole

Institutions: University of Minnesota, Emory University, Virginia Commonwealth University, University of Pennsylvania, Duke University, Inova Health System

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3136434435

FWCI:

Cites:

Cited by:

Related to: 10